Lifestyle
- Regular physical activity
- Stress management techniques
- Adequate sleep
Tumor Necrosis Factor Alpha · TNF-alpha · TNFa
TNF-α quantifies the level of tumor necrosis factor-alpha, a pro-inflammatory cytokine involved in systemic inflammation.
Reference ranges can vary based on laboratory methods and patient demographics.
Tumor Necrosis Factor-alpha (TNF-α) is a pro-inflammatory cytokine involved in systemic inflammation and is part of the cytokine family that stimulates the acute phase reaction. It is primarily produced by activated macrophages, but also by a variety of other cells including lymphocytes, mast cells, and certain tumor cells. TNF-α plays a crucial role in the immune response to infection and is involved in the regulation of immune cells, apoptosis, and inflammation. Clinically, elevated TNF-α levels are associated with a range of inflammatory and autoimmune diseases such as rheumatoid arthritis, psoriasis, and inflammatory bowel disease. It is also implicated in the pathogenesis of certain cancers and metabolic disorders like obesity. TNF-α inhibitors are used therapeutically to manage these conditions, highlighting its significance as a biomarker for disease activity and treatment response. For athletes and biohackers, TNF-α is of interest due to its role in inflammation and recovery. Chronic low-grade inflammation, as indicated by elevated TNF-α, can impair recovery and performance. Monitoring TNF-α levels may help optimize training and recovery strategies. However, TNF-α levels can be influenced by various factors including infections, stress, and circadian rhythms. It is important to consider these confounders when interpreting TNF-α levels. Fasting and time of day may also affect results, as cytokine levels can fluctuate throughout the day.
Klinische Bedeutung
Elevated TNF-α levels indicate active inflammation and are associated with autoimmune diseases, infections, and certain cancers. Reduced levels may suggest effective anti-inflammatory treatment or a resolution of inflammation.
Progressively rising TNF-α levels suggest worsening inflammation or disease activity. Re-test in 4-6 weeks if elevated.
Falling levels indicate a reduction in inflammation or effective treatment.
Re-test Interval
4-6 weeks if outside optimal range
Note:
Consult a healthcare provider before starting any new supplement regimen, especially if on medication.
Cytokine levels can vary diurnally; consistent timing for tests is recommended.
Testing Frequency
Frequency depends on clinical context; consult healthcare provider.
Correlated with
Current research suggests that the optimal reference ranges for TNF-alpha in various diseases, particularly in cancer and autoimmune disorders, remain poorly defined, leading to debates on its role as a reliable biomarker. Emerging research directions include exploring TNF-alpha's predictive value for responsiveness to anti-TNF therapies and its interactions with other inflammatory cytokines. However, clinical questions remain unanswered regarding the specific mechanisms by which TNF-alpha contributes to disease progression and the potential for targeted therapies.
840
Total Citations
3
Human/RCT
2.2
Avg. Influence
2025
Latest
Researchers reviewed the potential of salivary cytokines, including TNF-α, as diagnostic biomarkers for oral cancer. They noted that elevated levels of these cytokines are associated with cancer progression. The study suggests that saliva could be a cost-effective medium for early detection of oral squamous cell carcinoma.
This study reviewed the development and applications of anti-TNF-alpha therapies, which have significantly improved treatment for autoimmune diseases like rheumatoid arthritis and Crohn's disease. Researchers found that anti-TNF-alpha drugs are also being evaluated for other conditions, including viral infections and certain cancers. The search for biomarkers to predict patient response to these therapies was also discussed.
Researchers examined the role of TNF-alpha in COVID-19, finding that elevated levels are associated with severe disease outcomes. They noted that TNF-alpha contributes to lung injury and inflammation in COVID-19 patients. The study suggests that TNF-alpha could serve as a biomarker for prognosis and a target for therapeutic intervention.
This review explored the role of myeloperoxidase (MPO) in neuroinflammation and its relationship with TNF-alpha. Researchers noted that MPO can exacerbate inflammation and oxidative stress, which are linked to neurological disorders. The study suggests that targeting MPO may provide new diagnostic and therapeutic avenues for these conditions.
This review explored the role of chemerin and TNF-alpha in obesity-related inflammatory diseases. Researchers noted that elevated levels of TNF-alpha are associated with various inflammatory conditions and that chemerin may serve as a biomarker for tumors. The study suggests that understanding chemerin's mechanisms could lead to new treatments for inflammatory diseases.
Researchers conducted a meta-analysis to assess the link between serum TNF-α levels and recurrent spontaneous miscarriage (RSM). They found that TNF-α levels were significantly higher in RSM patients compared to controls, suggesting a potential role of TNF-α in miscarriage risk. The study highlights the need for standardized testing methods.
This review focused on the relationship between hypothyroidism and cardiovascular disease, noting that elevated TNF-alpha levels contribute to inflammation and atherosclerosis. Researchers found that managing thyroid hormone levels could mitigate cardiovascular risks associated with hypothyroidism. The study emphasizes the need for careful monitoring of thyroid function in patients with cardiovascular issues.
Researchers explored the dual roles of TNF-α in lung cancer, noting its potential to promote both tumor survival and immune response. They highlighted the importance of the balance between TNF-α forms and receptors in cancer progression. The study calls for further research into TNF-α as a biomarker for lung cancer treatment.
This meta-analysis investigated the relationship between TNF-alpha levels and diabetic retinopathy (DR). Researchers found that TNF-alpha levels were significantly different between DR patients and healthy controls, suggesting it may serve as a biomarker for DR. The study emphasizes the need for further research in this area.
Researchers reviewed non-invasive methods for detecting TNF-α in body fluids using electrochemical biosensors. They emphasized the importance of TNF-α as a marker for systemic inflammation and discussed the advantages of saliva, tears, and urine for monitoring health. The study points to the future potential of these biosensors in clinical settings.
1
Total Trials
174
Total Enrolled
National Taiwan University Hospital
174
2011
Evaluate the associations between aortic pulse wave, ankle-brachial index, aortic calcification and blood/serum biochemical markers, such as MPO, MMP-9, IL-6, adiponectin, TNF-alpha, of the patients in prevalent peritoneal dialysis patients.
Research publications about TNF-alpha over time
9totalLog lab results, track trends and optimize your biomarkers over time.
This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer